首页> 外文期刊>Bone >Timing of growth hormone treatment affects trabecular bone microarchitecture and mineralization in growth hormone deficient mice.
【24h】

Timing of growth hormone treatment affects trabecular bone microarchitecture and mineralization in growth hormone deficient mice.

机译:生长激素治疗的时机影响生长激素缺乏小鼠的小梁骨微结构和矿化。

获取原文
获取原文并翻译 | 示例
           

摘要

Growth hormone (GH) is essential in the development of bone mass, and a growth hormone deficiency (GHD) in childhood is frequently treated with daily injections of GH. It is not clear what effect GHD and its treatment has on bone. It was hypothesized that GHD would result in impaired microarchitecture, and an early onset of treatment would result in a better recovery than late onset. Growth hormone deficient homozygous (lit/lit) mice of both sexes were divided into two treatment groups receiving daily injections of GH, starting at an early (21 days of age) or a late time point (35 days of age, corresponding to the end of puberty). A group of heterozygous mice with normal levels of growth hormone served as controls. In vivo micro-computed tomography scans of the fourth lumbar vertebra were obtained at five time points between 21 and 60 days of age, and trabecular morphology and volumetric BMD were analyzed to determine the effects of GH on bone microarchitecture. Early GH treatment led to significant improvements in bone volume ratio (p=0.006), tissue mineral density (p=0.005), and structure model index (p=0.004) by the study endpoint (day 60), with no detected change in trabecular thickness. Trabecular number increased and trabecular separation decreased in GHD mice regardless of treatment compared to heterozygous mice. This suggests fundamental differences in the structure of trabecular bone in GHD and GH treated mice, reflected by an increased number of thinner trabeculae in these mice compared to heterozygous controls. There were no significant differences between the late treatment group and GHD mice except for connectivity density. Taken together, these results indicate that bone responds to GH treatment initiated before puberty but not to treatment commencing post-puberty, and that GH treatment does not rescue the structure of trabecular bone to that of heterozygous controls.
机译:生长激素(GH)在骨骼发育中至关重要,每天注射GH可以治疗儿童生长激素缺乏症(GHD)。尚不清楚GHD及其治疗对骨骼有什么作用。据推测,GHD会导致微体系结构受损,并且较早发作,较早发作治疗会导致更好的康复。将两性的生长激素缺陷型纯合(lit / lit)小鼠分为两个治疗组,分别从早期(21天龄)或晚期(35天龄,对应于末日)开始每天接受GH注射青春期)。一组具有正常生长激素水平的杂合小鼠作为对照。在21至60天年龄的五个时间点进行了第四腰椎的体内微计算机断层扫描,并分析了小梁的形态和体积BMD,以确定GH对骨微结构的影响。早期的GH治疗导致研究终点(第60天)的骨体积比(p = 0.006),组织矿物质密度(p = 0.005)和结构模型指数(p = 0.004)显着改善,但未发现小梁的变化厚度。与杂合小鼠相比,无论处理如何,GHD小鼠的骨小梁数目增加而骨小梁分离减少。这表明在GHD和GH处理的小鼠中,小梁骨的结构存在根本差异,这反映为与杂合对照相比,这些小鼠的小梁细化数量增加。除连通性密度外,晚期治疗组与GHD小鼠之间无显着差异。综上所述,这些结果表明骨骼对青春期之前开始的GH治疗有反应,但对青春期后开始的治疗无反应,并且GH治疗不能使小梁骨的结构恢复为杂合对照。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号